Free Trial

Provectus Biopharmaceuticals (PVCT) SEC Filings & 10K Form

Provectus Biopharmaceuticals logo
$0.11 0.00 (0.00%)
(As of 11/20/2024 ET)

Recent Provectus Biopharmaceuticals SEC Filings

DateFilerForm TypeView
11/14/2024
7:00 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
11:31 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:58 PM
Bailey Webster (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
7:01 PM
Lacey John III (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
7:06 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:56 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:58 PM
Provectus Biopharmaceuticals (Issuer)
Rodrigues Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
4:21 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
8:54 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
10:15 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
2:06 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
6:23 PM
Morris Jeffrey Allen (Filed by)
Provectus Biopharmaceuticals (Subject)
Form SC 13G
08/14/2024
6:19 PM
Morris Jeffrey Allen (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
12:21 PM
Provectus Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
2:31 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
4:20 PM
Provectus Biopharmaceuticals (Issuer)
Rodrigues Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
2:24 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
12:02 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
2:50 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
6:29 PM
Pershing Edward (Filed by)
Provectus Biopharmaceuticals (Subject)
Form SC 13D
07/02/2024
9:37 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
5:46 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
2:41 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
12:56 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
1:08 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:30 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
5:03 AM
Provectus Biopharmaceuticals (Filer)
Form DEFA14A
06/17/2024
4:58 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:32 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
1:43 PM
Provectus Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
12:33 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
9:54 AM
Provectus Biopharmaceuticals (Filer)
Form ARS
05/06/2024
12:56 PM
Provectus Biopharmaceuticals (Filer)
Form DEF 14A
05/06/2024
12:57 PM
Provectus Biopharmaceuticals (Filer)
Form DEFA14A
04/30/2024
11:20 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
12:10 PM
Provectus Biopharmaceuticals (Filer)
Form 10-K/A
04/26/2024
10:48 AM
Provectus Biopharmaceuticals (Filer)
Form PRE 14A
04/26/2024
8:00 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
10:08 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:58 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
2:45 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
04/09/2024
3:31 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
1:35 PM
Provectus Biopharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2024
11:10 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:48 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:49 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
9:58 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:29 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
8:22 AM
Provectus Biopharmaceuticals (Issuer)
Raines Heather (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
2:16 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
1:12 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
8:30 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
10:12 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:54 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
7:05 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2024
2:16 PM
Provectus Biopharmaceuticals (Issuer)
Raines Heather (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
4:29 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:21 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
1:55 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
10:39 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
11:49 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
5:51 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:PVCT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners